Picture of Zylox-Tonbridge Medical Technology Co logo

2190 Zylox-Tonbridge Medical Technology Co Cashflow Statement

0.000.00%
hk flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Annual cashflow statement for Zylox-Tonbridge Medical Technology Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-200-114-78.7100237
Depreciation
Non-Cash Items55.9-5.84162.12-17.1
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital14.21.812533.8128
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Payable / Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities-116-91.398.4174385
Capital Expenditures-89.6-145-191-191-111
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-1,23950.2-15.3-61066.5
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-1,328-95-206-801-44.7
Financing Cash Flow Items399-0.722-1.25-7.498.16
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities2,810-30.3-11.5-42-174
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash1,359-213-119-668161